These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 25797071

  • 1. Acute effects of Rho-kinase inhibitor fasudil on pulmonary arterial hypertension in patients with congenital heart defects.
    Xiao JW, Zhu XY, Wang QG, Zhang DZ, Cui CS, Zhang P, Chen HY, Meng LL.
    Circ J; 2015; 79(6):1342-8. PubMed ID: 25797071
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Acute effects of intravenous fasudil with different dosage on patients with congenital heart defects and severe pulmonary arterial hypertension].
    Ruan HY, Zhang YG, Liu R.
    Zhonghua Yi Xue Za Zhi; 2018 Mar 06; 98(9):678-681. PubMed ID: 29534403
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The acute effects of 30 mg vs 60 mg of intravenous Fasudil on patients with congenital heart defects and severe pulmonary arterial hypertension.
    Ruan H, Zhang Y, Liu R, Yang X.
    Congenit Heart Dis; 2019 Jul 06; 14(4):645-650. PubMed ID: 31166081
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Acute hemodynamic responses to adenosine and iloprost in patients with congenital heart defects and severe pulmonary arterial hypertension.
    Zhang DZ, Zhu XY, Meng J, Xue HM, Sheng XT, Han XM, Cui CS, Wang QG, Zhang P.
    Int J Cardiol; 2011 Mar 17; 147(3):433-7. PubMed ID: 20537740
    [Abstract] [Full Text] [Related]

  • 8. Inhaled Fasudil Lacks Pulmonary Selectivity in Thromboxane-Induced Acute Pulmonary Hypertension in Newborn Lambs.
    Hanson SFL, Terry MH, Moretta DT, Power GG, Wilson SM, Alam F, Ahsan F, Blood AB, Giri PC.
    J Cardiovasc Pharmacol Ther; 2018 Sep 17; 23(5):472-480. PubMed ID: 29756460
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Double-blind, placebo-controlled clinical trial with a rho-kinase inhibitor in pulmonary arterial hypertension.
    Fukumoto Y, Yamada N, Matsubara H, Mizoguchi M, Uchino K, Yao A, Kihara Y, Kawano M, Watanabe H, Takeda Y, Adachi T, Osanai S, Tanabe N, Inoue T, Kubo A, Ota Y, Fukuda K, Nakano T, Shimokawa H.
    Circ J; 2013 Sep 17; 77(10):2619-25. PubMed ID: 23912836
    [Abstract] [Full Text] [Related]

  • 13. Acute vasodilator effect of fasudil, a Rho-kinase inhibitor, in monocrotaline-induced pulmonary hypertension in rats.
    Jiang BH, Tawara S, Abe K, Takaki A, Fukumoto Y, Shimokawa H.
    J Cardiovasc Pharmacol; 2007 Feb 17; 49(2):85-9. PubMed ID: 17312448
    [Abstract] [Full Text] [Related]

  • 14. Effects of Fasudil on Patients with Pulmonary Hypertension Associated with Left Ventricular Heart Failure with Preserved Ejection Fraction: A Prospective Intervention Study.
    Zhang X, Zhang X, Wang S, Luo J, Zhao Z, Zheng C, Shen J.
    Can Respir J; 2018 Feb 17; 2018():3148259. PubMed ID: 29785232
    [Abstract] [Full Text] [Related]

  • 15. Cocktail of Superoxide Dismutase and Fasudil Encapsulated in Targeted Liposomes Slows PAH Progression at a Reduced Dosing Frequency.
    Gupta N, Rashid J, Nozik-Grayck E, McMurtry IF, Stenmark KR, Ahsan F.
    Mol Pharm; 2017 Mar 06; 14(3):830-841. PubMed ID: 28165252
    [Abstract] [Full Text] [Related]

  • 16. Hemodynamic Evaluation of Children with Persistent or Recurrent Pulmonary Arterial Hypertension Following Complete Repair of Congenital Heart Disease.
    Latus H, Wagner I, Ostermayer S, Kerst G, Kreuder J, Schranz D, Apitz C.
    Pediatr Cardiol; 2017 Oct 06; 38(7):1342-1349. PubMed ID: 28681131
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Analysis of pulmonary vasodilator responses to the Rho-kinase inhibitor fasudil in the anesthetized rat.
    Badejo AM, Dhaliwal JS, Casey DB, Gallen TB, Greco AJ, Kadowitz PJ.
    Am J Physiol Lung Cell Mol Physiol; 2008 Nov 06; 295(5):L828-36. PubMed ID: 18689606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.